| UBS MSCI EM INDEX FUND USD A ACC | RVI EMERGENTES | 36,14% | 62,02% | 40,27% | 126,34% |
| AB SICAV I-EUROPEAN EQUITY PORTFOLIO I EUR | RVI EUROPA | 20,71% | 41,06% | 52,17% | 126,33% |
| FIDELITY FUNDS-INSTITUTIONAL EMERGING MARKETS EQUITY I-ACC-USD | RVI EMERGENTES | 45,90% | 70,15% | 32,50% | 126,31% |
| SANTANDER ACCIONES ESPAÑOLAS, FI A | RV ESPAÑA | 27,93% | 81,23% | 122,04% | 126,29% |
| INVESCO FTSE 100 UCITS ETF ACC | RVI UK | 23,85% | 56,41% | 82,50% | 126,28% |
| MFS MERIDIAN CONTINENTAL EUROPEAN EQUITY FUND I1-GBP | RVI EUROPA EX-UK | 6,22% | 16,97% | 28,38% | 126,28% |
| BGF JAPAN FLEXIBLE EQUITY D2 EUR | RVI JAPÓN | 17,86% | 42,73% | 45,70% | 126,27% |
| AMUNDI MSCI JAPAN ESG BROAD TRANSITION INDEX RE CAP | RVI JAPÓN | 30,44% | 51,18% | 57,54% | 126,26% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | RVI BIOTECNOLOGÍA | 52,73% | 64,82% | 49,45% | 126,26% |
| UBS MSCI EM INDEX FUND EUR I-A ACC | RVI EMERGENTES | 35,89% | 61,86% | 40,26% | 126,25% |
